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In lung stereotactic body radiotherapy (SBRT), variability of intrafractional target 
motion can negate the potential benefits of four-dimensional (4D) treatment plan-
ning that aims to account for the dosimetric impacts of organ motion. This study 
used tumor motion data obtained from CyberKnife SBRT treatments to quantify 
the reproducibility of probability motion function (pmf) of 37 lung tumors. The 
reproducibility of pmf was analyzed with and without subtracting the intrafractional 
baseline drift from the original motion data. Statistics of intrafractional tumor 
motion including baseline drift, target motion amplitude and period, were also 
calculated. The target motion amplitude significantly correlates with variations 
(1 SD) of motion amplitude and baseline drift. Significant correlation between 
treatment time and variations (1 SD) of motion amplitude was observed in anterior–
posterior (AP) motion, but not in craniocaudal (CC) and left–right (LR) motion. 
The magnitude of AP and LR baseline drifts significantly depend on the treatment 
time, while the CC baseline drift does not. The reproducibility of pmf as a function 
of time can be well described by a two-exponential function with a fast and slow 
component. The reproducibility of pmf is over 60% for the CC motion and over 
50% for the AP and LR motions when baseline variations were subtracted from the 
original motion data. It decreases to just over 30% for the CC motion and about 
20% for the AP and LR motion, otherwise. 4D planning has obvious limitations 
due to variability of intrafractional target motion. To account for potential risks 
of overdosing critical organs, it is important to simulate the dosimetric impacts of 
intra- and interfractional baseline drift using population statistics obtained from 
SBRT treatments. 
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I. IntroductIon
Four-dimensional (4D) treatment planning aims to account for the effects of internal organ 
motion in lung radiotherapy. It has been demonstrated that the dosimetric effect of target motion 
can be modeled by convolving the probability motion function (pmf) with the static dose dis-
tribution or directly incorporating the pmf into the optimization problem.(1,2) However, these 
convolution-based methods do not deal with organ deformation during respiration. The other 
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common approach is 4D dose calculation. In this approach, dose distributions are calculated 
and/or optimized on multiple breathing geometries obtained from a 4D computed tomography 
(4D CT) dataset, and summed together using deformable image registration. The resulting 4D 
dose distribution explicitly accounts for the cumulative effect of temporal changes of anatomic 
structures.(3,4) Such 4D planning technique is particularly useful to incorporate the additional 
movement of beam aperture in dynamic multileaf (MLC)-based or robotic-based target track-
ing radiotherapy.(5,6)
The robustness of any 4D planning regime depends on the reliability of the motion model 
input. In fact, study using repeated 4D CT has demonstrated that tumor mobility increased 
between weeks during the treatment course.(7) Experiences from image-guided (IG) radiotherapy 
also indicated that target exhibited changes of characteristics of the periodic (cyclic) respiration-
induced motion and nonperiodic (ultracyclic) baseline motion, in spite of rather stable tumor 
trajectory between treatment fractions.(8) The random and systematic uncertainties of interfrac-
tional target position effectively vary the pmf and, consequently, the dose distribution.  
For stereotactic body radiotherapy (SBRT) of lung cancers, intrafractional variation of tumor 
motion may also be important due to the complex setup procedures and the long beam-on 
time leading to an increase of overall treatment duration. Purdie et al.(9) acquired cone-beam 
computed tomography (CBCT) before and after treatment delivery to assess the intrafractional 
errors of target positions, which included contributions from overall patient movement and 
target baseline drift. They found a correlation between the target position error and the treat-
ment time. Similarly, Sonke et al.(10) used respiratory-correlated CBCT (rCBCT) to quantify 
the intrafractional target position errors relative to bony anatomy (i.e., intrafractional baseline 
drift). They found systematic errors (1 SD) of 1.0, 1.4, and 0.6 mm, and random errors of 1.1, 
1.5, 0.7 mm in the CC, AP, and LR directions, respectively. Due to the constant treatment time, 
they did not observe a correlation between the drift of tumor baseline and the treatment time. 
On the other hand, Suh et al.(11) used continuous tumor motion data extracted from CyberKnife 
SBRT treatments to obtain statistics of intrafractional tumor motion. They estimated the overall 
mean cycle-to-cycle variations of tumor motion amplitude and period to be 0.2 cm and 0.8 s, 
respectively. However, none of these studies (and others) quantified how the variations of tumor 
motion amplitude and period and baseline affect the reproducibility of pmf.(12) Cai et al.(13) 
have employed dynamic MRI to study the reproducibility of interfractional lung pmf. However, 
their motion data was limited to 300 s, which were much shorter than the typical length of 
actual SBRT treatments (one-half to one hour, and even up to two hours in CyberKnife real-
time target tracking SBRT). It is the aim of this study to assess the intrafractional variations 
of tumor motion and the reproducibility of the pmf on a times scale that corresponds to actual 
SBRT treatments. It is expected that results obtained in this study shall shed insight into the 
appropriateness of 4D planning of SBRT for lung cancers.   
 
II. MAtErIALS And MEtHodS
A.  Acquisition and analysis of tumor motion data
Between 2008 and 2011, 37 lesions (15 lower-lobe tumors, 14 middle-lobe tumors, and eight 
upper-lobe tumors) of a total of 28 patients were treated with SBRT using the CyberKnife 
robotic radiosurgery system (Accuray Inc., Sunnyvale, CA). There were a total of 128 treat-
ment fractions. The target motion data of these patients were obtained from the log files of 
the Synchrony Respiratory Tracking System (RTS) (Accuray Inc. Sunnyvale, CA). Note that 
the Synchrony RTS does not track the tumor itself, but records the center-of-mass (COM) of 
the implanted fiducials as computed by the pair of stereoscopic images. For an elaboration 
of technical details about the tracking mechanism, see Seppenwoolde et al.(6) and Hoogeman 
et al.(14) The motion log file contained motion data in three principal directions in the format 
of t:x,y,z, where t is the time in seconds, x, y, and z are the target positions in millimeter (mm) 
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in the craniocaudal (CC), left–right (LR), and anterior–posterior (AP) directions. Note that 
the target motion was based on the estimate of the correlation model that was built using the 
external breathing signal and the internal fiducials COM’s position. Therefore, it did not strictly 
represent the true target positions. The mean correlation model errors have been estimated to 
be better than 0.3 mm.(14) 
Prior to the motion analysis, motion traces in each direction were plotted and visually 
inspected to remove the portions with significant artifacts. To reduce uncertainties of the results, 
the criteria of exclusion and inclusion of data points recommended by Suh et al.(11) were fol-
lowed. In our analysis, one fraction could generate more than one motion trace of shorter periods 
because the correlation model was forced to rebuild whenever the actual and estimated position 
of the center-of-mass of implanted fiducials deviated by 3 mm in a row. Furthermore, since 
couch movements to reposition the patient were not logged by the target localization system 
(TLS), there were no direct means to join datasets before and after the couch corrective move-
ments, unless manual efforts were taken to note these movements. In the following analysis, 
these short motion traces were combined by subtracting the difference of the last 30-second 
average of the motion data before model rebuilt and the first 30-second average of the motion 
data after model rebuilt from the motion data of the rebuilt model. This data joining procedure 
was illustrated in Fig. 1. To avoid serious error in the analysis of motion statistics, motion data 
were combined only if the mean amplitude of the rebuilt motion model was within the mean 
amplitude ± 2 SD of the beginning motion model. Such criteria was rather arbitrary, but was 
adopted to exclude obvious error resulting from the motion correlation model while not to 
overly exclude motion data that might represent the actual change of motion characteristics. 
Because the motion traces before and after model rebuild may exhibit different amplitudes, 
errors could occur at the connecting points between the fragmented motion data. However, 
the resulting errors in the determination of cycle-to-cycle period and amplitude were expected 
 
 
 
FIG. 1. (A) Two motion traces of the same treatment fraction were showed. They were joined by 
subtracting the difference of the last 30-second average of the motion data before model rebuilt (green 
solid line) and the first 30-second average of the motion data after model rebuilt (black solid line) from 
the motion data of the rebuilt model. (B) The data joining artifact was indicated. The red solid line 
represented the ultracyclic target baseline motion. (C) The complete time series of target motion after 
the data joining procedure was demonstrated. With the large number of motion cycles, the artifact of 
motion data joining is expected to contribute to negligible errors of the overall estimates of target 
motion amplitude and period.   
Fig. 1. Two motion traces (a) of the same treatment fraction are showed. They were joined by subtracting the difference of 
the last 30 s average of the motion data before model rebuilt (green solid line) and the first 30 s average of the motion data 
after model rebuilt (black solid line) from the motion data of the rebuilt model. The data joining artifact (b) as indicated; 
the red solid line represents the ultracyclic target baseline motion. The complete time series (c) of target motion after the 
data joining procedure was demonstrated. With the large number of motion cycles, the artifact of motion data joining is 
expected to contribute to negligible errors of the overall estimates of target motion amplitude and period.  
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to be averaged out given the large number of breathing cycles. Furthermore, the data joining 
procedure assumed negligible tumor baseline drift before and after intervening couch shifts. 
This assumption could introduce error of 1.9 mm (1 SD) in the baseline estimation, as showed 
in a recent study of diaphragm motion during CBCT acquisition.(15) In this work, 20 motion 
traces were reconstructed by combining motion traces belonging to two correlation models, 
and three motion traces were generated with traces from three correlation models of the same 
treatment fraction.  
For each motion trace, the peak-to-peak amplitude was determined by an in-house written 
code in MATLAB (The MathWorks, Inc. Natick, MA). The code included a low-pass (Gaussian) 
filter to reduce high frequency noise embedded in the original data, and used the MATLAB 
built-in algorithm to locate local maxima. Only motion traces of length > 1000 s were included 
in this analysis.
B.  Intrafractional variability of tumor motion baseline
Once the portions of the artifacts were removed, the intrafractional variability of the ultra-
cyclic baseline motion was estimated in a two-step process: 1) the reference baseline  was 
established with the first 100 s (starting from the 10th to 110th second) of the motion trace, 
and 2) a running mean (RM) for the motion traces with a 20 s moving window was created as 
an approximation of the baseline. 
The reason of using 100 s as an estimate of the reference baseline is that it roughly corre-
sponds to the duration needed to build a reliable correlation model with eight evenly distributed 
points along the breathing cycle (two at either extremes and the other six at the mid-exhale and 
mid-inhale phases), and that it roughly corresponds to the acquisition time of planning 4D CT 
and verification CBCT. The second step involved extracting the ultracyclic target motion from 
the motion trace to approximate the time series of mean target positions. For this study, a 20 s 
moving window was employed to create a RM of the target position inside the window. The 
evaluation of the baseline drift was started at 110 s (i.e., the next data point to ) and stopped 
at 10 s from the end of the trace.
c.  Intrafractional reproducibility of probability density motion function (pmf)
After the motion data was processed as described above, the pmf was calculated by binning 
the target displacement, with a constant bin size set to 0.05 mm. The reproducibility of intra-
fractional pmf was analyzed separately for the CC, AP, and LR target motions. The reference 
pmf was generated from the same motion data as the reference baseline. It was then compared 
to the pmfs that were generated every 100 s following the reference pmf to determine the 
reproducibility R as a function of time t:
  (1)
 
The reproducibility of pmf as a function of time R(t) was stopped until the remaining data 
were < 100 s. In addition, the influence of baseline drift on the reproducibility of intrafractional 
pmf was also evaluated by subtracting the ultracyclic baseline motion from the original motion 
data. This resulted in the reproducibility of pmf due to the cyclic tumor motion, Rc(t)  
    
  (2)
 
where the subscript c indicates the cyclic component of the tumor motion. 
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d.  Statistical analysis
Statistical correlations between variables were analyzed by linear regression, exponential 
regression, and ANOVA with two and more factors using the Statistical Toolbox of MATLAB. 
P-value for Pearson’s correlation (r) resulting from the linear regression was computed using 
a Student’s t-distribution. The Student’s t-test was also used to compare groups and variables. 
A p-value < 0.05 is considered statistically significant. 
 
III. rESuLtS 
A total of 154 motion traces were extracted. The longest and shortest durations were 6000 s and 
1200 s (median = 3400 s), respectively. The principal motion coincides with the CC direction. 
There is an observable trend of increasing CC, AP, and LR motion amplitude in lower lobe 
tumors than upper and middle lobe tumors (p < 0.05). The overall mean of individual treatment 
fraction means of target motion amplitude is 6.0 ± 4.6 mm (range: 0.2–18.7 mm), 1.7 ± 1.2 mm 
(0.2–5.8 mm), and 0.9 ± 0.8 mm (0.0–3.7mm) in the CC, AP, and LR directions, respectively. 
The overall target motion period is 3.6 ± 0.6 s, with individual treatment fraction means ranging 
from (2.0–5.6 s). Lengths of the exhale and the inhale period of the patient population range 
from 0.9–2.2 s (mean : 1.5 s) and 1.1–3.4 s (mean : 2.0 s), respectively. 
In Fig. 2, the linear regressions show increasing variability of intrafractional target motion 
amplitude (1 SD) with the motion amplitude in all directions (CC: r = 0.80, p < 10-30; AP: r = 
0.76, p < 10-24; and LR: r = 0.76, p < 10-24). From Fig. 3, it was observed that the correlations 
of the motion amplitude variability and treatment time are moderate for the AP motion and 
weak for the CC and LR motions. ANOVA indicates that for the CC and LR directions, the 
variability of motion amplitude significantly depends on the tumor location (p < 0.05) but not 
on the treatment time (p = 0.98 for CC, and p = 0.073 for LR), whereas for the AP direction the 
variability depends on both tumor site (p = 0.004) and treatment time (p = 0.002). Variations 
(1 SD) of the exhale and inhale lengths versus the breathing cycle periods are plotted in Fig. 4. 
 
 
 
 
FIG. 2. Linear regressions of the motion amplitude and the motion variability (1 SD) in the 
cranio-caudal (A), anterior-posterior (B), and left-right (C) directions. Each circle represents each of 
the 128 motion traces. The linear fits and Pearson’s correlation coefficients of the data are also given. 
(D) Box-and-Whisker plot of the coefficient of variation (CV) of each motion component is shown. 
Outliers with a value that is more than 1.5 times the interquartile range away from the top or bottom of 
the box are marked with a red + sign.      
Fig. 2. Linear regressions of the motion amplitude and the motion variability (1 SD) in the craniocaudal (a), anterior–
posterior (b), and left–right (c) directions. Each circle represents each of the 128 motion traces. The linear fits and Pearson’s 
correlation coefficients of the data are also given. Box-and-whisker plot (d) of the coefficient of variation (CV) of each 
motion component is shown. Outliers with a value that is more than 1.5 times the interquartile range away from the top 
or bottom of the box are marked with a red + sign.
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A slightly higher correlation is observed between the breathing cycle period and the exhale 
length (r = 0.94) than between the breathing cycle period and the inhale length (r = 0.87). 
Statistically, difference of motion period between lower lobe tumors and upper and middle 
tumors is insignificant (3.5 s vs. 3.7 s; p = 0.08). However, the F-test shows greater variance 
of the length of exhale state than inhale state (p < 10-6) of individual treatment fractions. 
Figure 5 shows distribution of the baseline drift in each direction and the distribution of the 
3D baseline drift. The population statistics in terms of group mean, systematic, and random 
 
 
 
FIG. 3. Relationship between variability of motion amplitude (1 SD) and time for each motion axis. 
Each circle represents each of the 128 motion traces. The red lines are the best fits in the least-square 
sense. The Pearson’s correlation coefficients r are shown. 
 
 
 
FIG. 4. Variation (1 SD) of cycle period was plotted against the variations (1 SD) of the length of 
exhale (blue dot) and inhale (red dot) states. Each circle represents eac  of the 128 motion traces. The 
linear fits and Pearson’s correlation coefficients are also given.   
Fig. 3. Relationship between variability of motion amplitude (1 SD) and time for each motion axis. Each circle represents 
each of the 128 motion traces. The red lines are the best fits in the least-square sense. The Pearson’s correlation coef-
ficients r are shown.
Fig. 4. Variation (1 SD) of cycle period was plotted against the variations (1 SD) of the length of exhale (blue dot) and 
inhale (red dot) states. Each circle represents each of the 128 motion traces. The linear fits and Pearson’s correlation 
coefficients are also given. 
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errors are summarized in Table 1. Drifts are predominately towards the patients’ superior (or 
exhale), posterior, and left. Of the 128 individual treatment fractions, 51% and 18% of them 
show CC baseline drift ≥ 1 and ≥ 3 mm, 30% and 3% show AP baseline drift ≥ 1 and ≥ 3 mm, 
and 15% and 2% show LR baseline drift ≥ 1 and ≥ 3 mm. Over the entire treatment, 41%, 32%, 
and 11% of the 37 targets show mean baseline drift > 1 mm in the CC, AP, and LR directions, 
respectively. In Fig. 6, the variation of tumor motion and its associated baseline drift is shown. 
Coefficients of Pearson’s correlations between the baseline drift and the motion amplitude, and 
between the baseline drift and the treatment duration, are listed in Table 2. Results presented 
in bold are statistically significant. Moderate correlation of intrafractional baseline drift and 
motion amplitude was observed in each motion direction. The reported significance of correla-
tion coefficients in Table 2 is independent of tumor locations. 
To illustrate how changing motion amplitude, period, and baseline affects the intrafractional 
reproducibility of pmf, the per-100 s pmfs are shown for an upper lobe tumor in Fig. 7. The 
reproducibility of the per-100s pmfs is strongly patient-dependent. As shown in Fig. 7, the pmf 
of another lower lobe tumor is seen to be highly reproducible once the baseline variation was 
subtracted from the original motion data. For the entire population, the reproducibility of pmf 
calculated without and with subtraction of baseline (i.e. R(t) according to Eq. (1) and Rc(t) 
according to Eq. (2)) is shown in Fig. 8. It was found that R(t) and Rc(t) can be well described 
by a two-exponentials function with a fast and slow decay component. Coefficients of the fitted 
two-exponentials function, A0 × exp(A1 × t) + A2 × exp(A3 × t), are given in Table 3. For the 
R(t), the slow decay component is dominant in each motion direction. For the Rc(t), the slow 
decay component is dominant in the AP motion. For the CC motion, R(t) are 0.57, 0.49, 0.40, 
and 0.37, and Rc(t) are 0.64, 0.61, 0.56, and 0.57 at 5, 10, 30, and 45 minutes, respectively. 
Differences at the corresponding time intervals are 0.07 (7%), 0.11 (11%), 0.16 (16%), and 0.2 
(20%), indicating that the influence of baseline variation increases with time. 
 
 
 
 
FIG. 5. Distribution of the intrafractional baseline drift in each direction. The 3D baseline drift is 
also given. The solid lines are normal distribution fits and the thin dotted lines indicate means of the 
baseline drifts. 
Fig. 5. Distribution of the intrafractional baseline drift in each direction. The 3D baseline drift is also given. The solid 
lines are normal distribution fits and the thin dotted lines indicate means of the baseline drifts.
Table 1. Population statistics of intrafractional baseline variation.
  Craniocaudal (mm) Anterior–Posterior (mm) Left–Right (mm) 3D (mm)
 GM -1.2 -0.7 0.2 1.8
	 Σ	 1.5 0.7 0.5 1.4
	 σ	 1.9 1.0 0.6 2.3
GM = group mean; Σ = systematic error; σ = random error.
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FIG. 6. Illustration of the variation of tumor motion in the each direction for one selected patient. 
The blue solid lines are the original motion data, green lines show the baselines and the red dotted lines 
are the original motion data subtracting the baseline (i.e. cyclic motion). The CC baseline drift reaches 
a minimum of -4.0 mm halfway through the treatment and return to -0.2 mm at the end of the 
treatment.  
 
Fig. 6. Illustration of the variation of tumor motion in the each direction for one selected patient. The blue solid lines are 
the original motion data, green lines show the baselines, and the red dotted lines are the original motion data subtracting 
the baseline (i.e., cyclic motion). The CC baseline drift reaches a minimum of -4.0 mm halfway through the treatment 
and returns to -0.2 mm at the end of the treatment. 
Table 2. Correlations of the magnitude of intrafractional baseline drift ith the amplitude of intrafractional target 
motion and treatment time.
 Baseline 
  Craniocaudal Anterior–Posterior Left–Right
 motion amplitude 0.42  0.37 0.36
 time 0.08 0.26  0.16
Values are the Pearson’s correlation coefficients r, and values presented in bold are statistically significant.
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Fig. 7. Calculated probability motion functions (pmf) of intrafractional target motion without subtraction of target baseline 
motion (i.e., ultracyclic plus cyclic target motion (a)-(f)), and with subtraction of the target baseline motion (i.e., cyclic 
target motion (g)–(l)), for a lower- and upper-lobe tumor. Each red solid line represents the per-100 s pmf, and the black 
solid line is the reference pmf calculated using the first 100 s motion data. The blue dotted line is the averaged pmf of the 
entire treatment. The upper-lobe tumor is not only associated with noticeable baseline variation, but also associated with 
significant variability of target motion amplitude and period. The lower-lobe tumor, on the other hand, is associated with 
excellent reproducibility of the pmf in spite of the baseline variations. 
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IV. dIScuSSIon
This study analyzed tumor motion data obtained from the log files in CyberKnife real-time target 
tracking SBRT. Previous studies that employ 4D simulation/cone-beam CT provided estimate of 
tumor location errors and evaluation of motion trajectory at certain time points (e.g., before and 
after the treatment).(16-18) Continuous fluoroscopic imaging has the potential to track the tumor 
motion trajectory throughout the treatment, but it raises concerns of additional exposure to the 
patient, which requires substantial justification.(8,19) This study inferred the tumor location from 
the fiducial markers implanted in or near the tumor, and derived the motion of the tumor from 
continuously updated correlation model based on the external breathing signal and the internal 
marker position. It is known that correlation between the internal markers and the tumor is not 
perfect(20) and correlation error between the external breathing signal and the internal markers 
exists,(14) but the correlation motion data still offers valuable information about the continuous 
motion of tumor within a time frame relevant to CyberKnife SBRT and beam-gated SBRT. 
For our patient population, the overall cycle-to-cycle motion amplitude in the principal 
motion axis (craniocaudal) is 6.0 ± 4.6 mm (SD), which is close to means of 5.0 ± 1.6 mm and 
9.9 ± 6.4 mm reported by Suh et al.(11) and Guckenberger et al.,(16) respectively. Similarly, the 
overall cycle-to-cycle period is 3.6 ± 0.6 s (SD), which is very similar to the mean of three 
 
 
 
FIG. 8. Calculated reproducibility of per-100 s probability motion functions starting at the 110
th
 
second up to the 3400
th
 second (median treatment length of the patient group). The red triangle 
corresponds to the motion data with subtraction of the ultracyclic baseline (i.e. cyclic motion) and the 
blue square is the original motion data without subtraction of the baseline (i.e. the cyclic plus 
ultracyclic motion), respectively. The black and green lines are the two-exponential fits to the data 
using the Levenberg-Marquardt algorithm. R
2
 of the fits are also given.  
 
Fig. 8. Calculated reproducibility of per-100 s probability motion functions starting at the 110th second up to the 3400th 
second (median treatment length of the patient group). The red triangle corresponds to the motion data with subtraction 
of the ultracyclic baseline (i.e., cyclic motion) and the blue square is the original motion data without subtraction of the 
baseline (i.e., the cyclic plus ultracyclic motion), respectively. The black and green lines are the two-exponential fits to 
the data using the Levenberg-Marquardt algorithm. R2 of the fits are also given. 
Table 3.  Coefficients of the two-exponential fits to the reproducibility of probability motion function (pmf) calculated 
for the motion data including baseline R(t) and excluding baseline Rc(t).
 A0 A1 A2 A3 R
2
R(t)    
  CC 1.7E-01 -2.4E-03 4.9E-01 -1.0E-4
 (1.4E-01, 2.1E-01) (-3.5E-03, -1.2E-03) (4.6E-01, 5.3E-01) (-1.4E-04,-8.4E-05) 
0.98
  AP 3.9E-01 -1.5E-03 2.8E-01 -9.23E-05
 (3.3E-01, 4.6E-01) (-1.9E-03, -1.0E-03) (2.0E-01, 3.5E-01) (-1.8E-05,-4.5E-06) 
0.99
  LR 2.7E-01 -2.9E-03 4.1E-01 -2.8E-04
 (2.3E-01, 3.2E-01) (-3.9E-03, -1.9E-03) (3.7E-01, 4.5E-01) (-3.2E-04,-2.4E-04) 
0.99
     
Rc(t)    
  CC 1.2E-01  -2.2E-03  5.9E-01 -1.9E-05
 (8.9E-2, 1.4E-01) (-3.5E-03, -1.0E-03)  (5.7E-01, 6.1E-03)  (-3.3E-05,-4.2E-06) 
0.92
  AP 2.5E-01  -9.92E-04 4.6E-01 -1.6E-06
 (1.5E-01, 3.4E-01)  ( 1.5E-03, -4.7E-04) (3.6E-01, 5.7E-01)  (-6.0E-05,-5.7E-05) 
0.98
  LR 1.7E-01  -3.7E-03  5.6E-01 -5.9E-05
 (1.3E-01, 2.2E-01) (-5.3E-03, -2.0E-03) (5.4E-01, 5.8E-01)  (-7.3E-05,-4.6E-05) 
0.96
Values given in brackets are the 95% confidence intervals of the fit coefficients.
CC = craniocaudal motion; AP = anterior–posterior motion; LR = left–right motion.
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other patient populations (3.7 s).(8,11,20) Unlike the CC motion that shows greater amplitude in 
lower lobe tumors than in upper and middle lobe tumors, the motion period shows no noticeable 
dependence of the tumor location. In this work, we found that the exhale length is more variable 
than the inhale length. This implies that the dose-weighting scheme of 4D dose accumulation 
shall have greater uncertainty contributing from the exhale phases. 
Previously, Bissonnette et al.(12) found that the inter- and intra-acquisition variability of tumor 
mobility increased with the averaged motion amplitude. The study also found that the motion 
amplitude is not only a significant predictor of the intrafractional variability (1 SD) of tumor 
motion, but also a significant predictor of the magnitude of intrafractional baseline variation 
in each direction. This suggests that larger PTV margin may be needed for lower lobe tumor 
in nontarget-tracking SBRT treatments. Several studies have showed that active breath control 
and abdominal compression are effective to limit motion amplitude, but these techniques also 
resulted in greater variability of target position and motion amplitude,(12,21) and are unnecessary 
and impractical in target-tracking SBRT concerning the long treatment time. Therefore, the need 
of larger margin for lower lobe tumors in conventional SBRT treatments remains, since motion 
reducing techniques are frequently applied to these tumors with the greatest mobility.
From the results of Fig. 3 and Table 2, neither the variability of cyclic (CC, LR, and 3D) 
target motion nor the ultracyclic (CC and 3D) baseline drift appears to increase or decrease with 
treatment time for the scale from 1200 s to 6000 s. As previously demonstrated by Guckenburger 
et al.(16) using four repeated 4D CT scans at ten-minute intervals, the intrafractional tumor 
motion was relatively stable, although significant variations were possible in patients with poor 
pulmonary function. Bisonnette and colleagues similarly reported that the tumor motion varia-
tion was limited to < 1 mm and did not differ by the treatment fraction time. For a series of 129 
patients from the United States using 3D CBCT, Shah et al.(17) showed that the intrafractional 
(3D) baseline drift > 5 mm was significantly more frequent when treatment time was longer 
(22.6 ± 5.9 min vs. 20.7 ± 4.9 min), and the (3D) baseline drift > 2 mm was found to correlate 
with longer treatment times. As demonstrated in Fig. 6, the baseline could deviate from its 
starting position in the middle of the treatment and return to nearly the starting position at the 
end of the treatment. Therefore, taking samples of the tumor baseline position at the start and 
at the end of the treatment is likely to exclude significant change in the middle of the treatment, 
leading to underestimation of the intrafractional baseline drift. For the CC motion, the mean 
baseline drift estimated using the entire time series and estimated using the first 100 s and the 
last 100 s (a scenario corresponds to using CBCT) differs by 0.8 mm. Despite the notable dif-
ferences between this study using motion data from the entire treatment and others using 4D CT 
or CBCT to derive the baseline position, the calculated statistics of the intrafractional baseline 
drift is remarkably similar.(10,16,18) The results of Sonke et al.(10) and ours similarly indicated 
posterior and superior baseline drifts, whereas Guckenberger et al.(16) indicated posterior and 
inferior drifts. It is unknown whether the directions are associated with the gravity and other 
physio- and psychological processes, such as gradual relaxation of muscle and stress. 
Constant motion pattern is the fundamental assumption for most 4D treatment planning 
strategy. Figure 7 clearly shows that this assumption hardly holds. The reproducibility of pmf is 
affected by not only the cyclic target motion but also the ultracyclic target baseline drift (Fig. 8). 
The influence of baseline variation is more important in the first 15 minutes and then gradually 
diminishes. It is also more important in the AP direction. We found that the reproducibility of 
population pmf decays following a two-exponentials function that has a fast and slow decay 
component. The underlying mechanisms of the fast and slow decay are not fully understood. 
One possible explanation for the fast decay component is the psychological nervousness of 
the patient during the beginning of treatment. For the AP motion, the weight of the fast decay 
component is larger that of the slow decay component in the R(t) curve and becomes smaller in 
the Rc(t) curve. This signifies that the fast decay component is strongly related to the ultracyclic 
baseline drift. The observed motion reproducibility curve shown in Fig. 8 seems to support 
our clinical practice of allowing patients to rest on the CT scanner couch for about ten minutes 
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before the 4D CT simulation. Overall, the cyclic target motion is relatively stable over time, 
with reproducibility over 50% for the AP and LR motions, and 60% for the CC motion up to 
50 minutes.
The general approach of 4D planning is to accumulate dose using a patient breathing model. 
The ultimate question is whether the respiratory phases correspond to the exact spatial location 
over the fraction as it had been in the simulation 4D CT images. Attempts have been made 
to incorporate such variability of the pmf into 4D planning, but that requires estimation and 
generation of error bars associated with the pmf.(2) As demonstrated by Fig. 7, the shape of the 
pmf can be far more “random” than those used to test the robustness of different probabilistic 
optimization algorithms.(2,22) It has been demonstrated that target tracking techniques such as 
dynamic MLC tracking, robotic respiratory tracking, and tumor trailing strategy based on the 
moving average algorithm have the ability to adapt the baseline variation, but such adaptation is 
hardly reflected in the 4D dose calculation. Recently, Chan et al.(23) have demonstrated that the 
sensitivity of 4D dose calculation to the variation of target motion differed by organs of interest 
in target-tracking SBRT, with the greatest dosimetric errors observed in structures that were 
static or moved asynchronously with respect to the tracking object. Since planning risk volumes 
(PRV) have the limitations in serially functioning organs such as the spinal cord,(24) we suggest 
to simulate the intrafractional (and also interfractional) baseline drifts using the population data 
during treatment planning to avoid potential risks of overdosing these critical organs. 
 
V. concLuSIonS
This study shows that intrafractional target motion, excluding the influence of baseline drift, is 
relatively stable with reproducibility over 60% in CC and 50% in AP and LR directions within 
a time frame that is typical of lung SBRT. However, tumor baseline can change substantially 
in SBRT and effectively reduces the reproducibility of pmf in the majority of patients. These 
results suggest that methods based on dose convolution technique or explicit 4D dose calcula-
tion may only serve as a first-order approximation to the dosimetric effects of target motion. 
It may be important to simulate the interfractional in addition to intrafractional baseline drifts 
to avoid potential risks of normal tissue complications, particularly if tumor is close to the 
organs at risk.
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